371 related articles for article (PubMed ID: 26100526)
1. Voriconazole: a novel treatment option for cryptococcal meningitis.
Yao Y; Zhang JT; Yan B; Gao T; Xing XW; Tian CL; Huang XS; Yu SY
Infect Dis (Lond); 2015; 47(10):694-700. PubMed ID: 26100526
[TBL] [Abstract][Full Text] [Related]
2. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
[TBL] [Abstract][Full Text] [Related]
3. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
4. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
Kammalac Ngouana T; Dongtsa J; Kouanfack C; Tonfack C; Fomena S; Mallié M; Delaporte E; Boyom FF; Bertout S
J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal meningitis in AIDS.
Iyer RS; Banker DD
Indian J Med Sci; 2002 Dec; 56(12):593-7. PubMed ID: 14514241
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
Maher D; Mwandumba H
J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
[TBL] [Abstract][Full Text] [Related]
7. 'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays.
Katchanov J; von Kleist M; Arastéh K; Stocker H
QJM; 2014 Oct; 107(10):799-803. PubMed ID: 24722846
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcal meningitis in acquired immunodeficiency syndrome.
Kalra SP; Chadha DS; Singh AP; Sanchetee PC; Mohapatra AK
J Assoc Physicians India; 1999 Oct; 47(10):958-61. PubMed ID: 10778686
[TBL] [Abstract][Full Text] [Related]
9. [Cryptococcal meningitis in children: description of 3 cases].
Ndiaye M; Diagne NR; Seck LB; Sow AD; Sène MS; Diop AG; Sow HD; Ndiaye MM
Med Trop (Mars); 2011 Apr; 71(2):176-8. PubMed ID: 21695878
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
12. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment.
Gupta C; Dogra P; Jain V; Kaur R; Sharma JB
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116217. PubMed ID: 38513558
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features of cryptococcal meningitis in HIV-AIDS patients.
Deo S
J Assoc Physicians India; 1995 Oct; 43(10):724. PubMed ID: 8773019
[No Abstract] [Full Text] [Related]
14. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.
Katchanov J; Branding G; Jefferys L; Arastéh K; Stocker H; Siebert E
Int J STD AIDS; 2016 Feb; 27(2):110-7. PubMed ID: 25693580
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcal meningitis in AIDS.
Ennis DM; Saag MS
Hosp Pract (Off Ed); 1993 Oct; 28(10):99-102, 105-7, 111-2. PubMed ID: 7691857
[No Abstract] [Full Text] [Related]
17. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
18. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
[No Abstract] [Full Text] [Related]
19. [Neurologic cryptococcosis: meningitis of the immunosuppressed patient].
Kallel K; Mejri H; Belhadj S; Boussen N; Kilani B; Zouiten F; Ben Abid H; Zribi A; Chaker E
Tunis Med; 1999 Jan; 77(1):45-9. PubMed ID: 10333698
[No Abstract] [Full Text] [Related]
20. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
